AAAAAA
Results:
1-11
|
Results: 11
Authors:
MONGKONSRITRAGOON W
KIMLINGER T
AHMANN G
GREIPP P
Citation: W. Mongkonsritragoon et al., 2-COLOR FLOW CYTOMETRIC MEASUREMENT OF FUNCTION OF THE P-GLYCOPROTEINEXTRUDING PUMP ON PLASMA-CELL LINES USING DAUNORUBICIN AND B-B4 MONOCLONAL-ANTIBODY, Blood, 90(10), 1997, pp. 4104-4104
Authors:
KAY NE
LEONG T
KYLE RA
GREIPP P
BILLADEAU D
VANNESS B
BONE N
OKEN MM
Citation: Ne. Kay et al., CIRCULATING BLOOD B-CELLS IN MULTIPLE-MYELOMA - ANALYSIS AND RELATIONSHIP TO CIRCULATING CLONAL CELLS AND CLINICAL-PARAMETERS IN A COHORT OF PATIENTS ENTERED ON THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-IIIE9486 CLINICAL-TRIAL, Blood, 90(1), 1997, pp. 340-345
Authors:
LIU PC
LEONG T
QUAM L
BILLADEAU D
KAY NE
GREIPP P
KYLE RA
OKEN MM
VANNESS B
Citation: Pc. Liu et al., ACTIVATING MUTATIONS OF N-RAS AND K-RAS IN MULTIPLE-MYELOMA SHOW DIFFERENT CLINICAL ASSOCIATIONS - ANALYSIS OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-III TRIAL, Blood, 88(7), 1996, pp. 2699-2706
Authors:
DALTON W
GREIPP P
GREENBERG P
STIFF P
BALLESTER O
FRIEDENBERG W
SALMON S
KYLE R
CHARNICK S
PEARCE T
Citation: W. Dalton et al., PHASE-I STUDY OF THE CHEMOSENSITIZER SDZ PSC-833 IN COMBINATION WITH VAD CHEMOTHERAPY TO REVERSE MULTIDRUG-RESISTANCE, Blood, 88(10), 1996, pp. 2638-2638
Authors:
KAY NE
OKEN MM
KYLE R
VANNESS B
KALISH L
LEONG T
GREIPP P
Citation: Ne. Kay et al., SEQUENTIAL PHENOTYPING OF MYELOMA PATIENTS ON CHEMOTHERAPY - PERSISTENCE OF ACTIVATED T-CELLS AND NATURAL-KILLER-CELLS, Leukemia & lymphoma, 16(3-4), 1995, pp. 351-354
Authors:
COGEN F
GREIPP P
Citation: F. Cogen et P. Greipp, CAPILLARY LEAK SYNDROME (CLS) PRESENTING AS IDIOPATHIC ANAPHYLAXIS (A), Journal of allergy and clinical immunology, 95(1), 1995, pp. 367-367
Authors:
MILLER H
LEONG T
KHANDEKAR J
GREIPP P
KYLE R
KRAM J
Citation: H. Miller et al., PACLITAXEL AS THE INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM) AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) STUDY, Blood, 86(10), 1995, pp. 738-738
Authors:
KAY N
LEONG T
VANNESS B
OKEN M
GREIPP P
BONE N
BILLADEAU D
KYLE R
Citation: N. Kay et al., CIRCULATING CD19-CELLS IN MULTIPLE-MYELOMA - PHENOTYPIC AND MOLECULARANALYSIS OF ECOG TRIAL E9486( BLOOD)9487/, Blood, 86(10), 1995, pp. 1088-1088
Authors:
VANNESS B
LEONG T
QUAM L
LIU P
BILLADEAU D
KAY N
OKEN MM
GREIPP P
KYLE R
Citation: B. Vanness et al., DISTINCT RAS MUTATIONS IN MULTIPLE-MYELOMA (MM) CORRELATE WITH TUMOR BURDEN AND SURVIVAL - ANALYSIS OF ECOG PHASE-III TRIAL, Blood, 86(10), 1995, pp. 1755-1755
Authors:
KAY NE
OKEN MM
BONE N
KYLE RA
GREIPP P
VANNESS B
LEONG T
Citation: Ne. Kay et al., CIRCULATING CD19(-CELL LEVELS IN MYELOMA() BLOOD), Blood, 86(10), 1995, pp. 4000-4000
Authors:
BILLADEAU D
AHMANN G
GREIPP P
VANNESS B
Citation: D. Billadeau et al., THE BONE-MARROW OF MULTIPLE-MYELOMA PATIENTS CONTAINS B-CELL POPULATIONS AT DIFFERENT STAGES OF DIFFERENTIATION THAT ARE CLONALLY RELATED TO THE MALIGNANT PLASMA-CELL, The Journal of experimental medicine, 178(3), 1993, pp. 1023-1031
Risultati:
1-11
|